2022 has been a remarkable year for Eleos Health. The company:

• Launched the CareOps Automation movement, mainstreaming augmented intelligence as a technology that gives behavioral health professionals the support they deserve.
• Completed its first Randomized Controlled Trial (RCT), demonstrating that providers using Eleos achieve 3-4x better outcomes and 2x better patient engagement in real-world settings (stay tuned for the published study).
• More than doubled its customer base to over 30 leading behavioral health organizations across 17 states, adding nine new states and growing revenue by 3x
• Helped providers increase the average number of evidence-based techniques used per session by an average of over 30%.
• Reached 260 days worth of documentation time saved to date for clinicians across the country, averaging a 50% reduction in documentation time and unlocking 20% more time available for client care
• Raised $20M in Series A funding and expanded their team by 70%  

But the real essence of a year at Eleos can’t be captured by stats – so we sat down with co-founder and CEO, Alon Joffe, to talk about successes, challenges, and what’s to come.

The Best of 2022

The past year brought a lot of accomplishments for Joffe and his team, but he’s most proud of his impact on communities.

“It’s a privilege to be able to serve these communities and help organizations,” Joffe shared. “We work with amazing leaders who genuinely care about their population and genuinely care about their clinicians. There’s a level of customer service that we bring them, a level of innovation, and it’s all centralized around the clinician.

For me, when I’m hearing feedback from the clinicians, that’s worth everything, right? That’s our why- when we hear a clinician who tells us, “Eleos saved me so much time, I stopped writing notes on my weekends, and I’m able to deliver better care to my clients.” For me, that’s the core of what we’re trying to do here.”

When Joffe listened to feedback from a clinician who had been using Eleos software for their documentation, that sense of accomplishment really struck home.

“A clinician told one of our customer success folks: ‘Just don’t take my Eleos away.’ And for me, that shows the level of value that clinicians get out of the solution.”

Customer feedback isn’t the only evidence of Eleos’ impact on mental health, though.

“We hold ourselves accountable to the outcomes- we ran a randomized controlled trial, actually seeing that it improves people’s lives, seeing that it improves usage of evidence-based practices and that it saves clinicians a lot of time.

That was another moment where I felt really proud. Our Chief Clinical Officer told me, “Hey, we’ve analyzed the outcomes from the randomized controlled trial. We’re actually seeing three to four times improvement in outcomes.” And we did it in a rural community with a complex Medicare/Medicaid population. It’s real-world data on real-world treatment. And we also compared that to treatment as usual, whereas a lot of companies just compare it to doing nothing. So for me, that was a moment where I said, wow. Okay. We’re doing something really meaningful here.”

Taking Stock of Missed Opportunities

A year-end reflection is also an opportunity to identify potential course corrections for the upcoming year. Joffe was quick to recognize things they could have done differently.

“It’s important for us to cultivate meaningful relationships with our customers. And we did that in 2022. Being in person and visiting them in person is really valuable, and I wish we could have done that more.

I wish we could have been at every site, meeting every clinician. To me, that’s really meaningful- to provide that level of customer service and actually meet the people, to know them and see firsthand what problems they’re dealing with.

It’s something that we’re going to continue to double down on in 2023, and I wish we could have done more of it in 2022.”

A Look Ahead to 2023

Joffe, a leader who has a finger on the pulse of the mental health industry, had some insights on what 2023 might hold.

“2023 is going to be the year of transition from pure access to access plus quality. 

Covid brought a tsunami of demand. And the entire industry was scrambling around access, right? It makes sense. Access is still a huge problem, especially in rural areas. 

But we’re coming to the realization that you can’t have access without quality. If you only have access without quality, you have a leaking bucket. Members and consumers are getting care, but they don’t improve, and the cycle just keeps on spinning. And demand keeps building up.

Given the shortage of clinicians, given that we need so many more clinicians in the US today, we need to put a stop to the leaking and actually make sure that there is quality in their outcomes and that people are improving. 

In 2023, we’re going to see a lot of pressure from different stakeholders – whether it’s principal consumers themselves, employers, health plans, providers, or legislators – to see outcomes. To see real evidence that what they’re paying for, and the treatment they’re getting is effective.

It’s going to start in 2023, and it’s going to continue in the following years. But to me that’s the theme of 2023 – it’s that shift from access to quality.”

According to Joffe, Eleos’s solution provides a unique leg-up to organizations that want to be proactive in the shift from access to quality.

“If you want to improve your outcomes, you need to measure them. It’s very difficult to prove something if you don’t measure it.

Then the question becomes, “What do I measure?” 

Do I measure patient-reported outcomes? Do I measure usage of evidence-based practices? Do I measure satisfaction?

Definition of value in behavioral health is elusive, but Eleos is well-positioned to capture all of the above in a way that does not interfere with the clinical workflow – and that’s going to be key. 

If you’re a CEO running a behavioral health organization, and you want to measure that quality- you want to prove that quality-  you want to do it in a way that is the least intrusive and brings the least disruption to your clinicians’ workflow.

We know that roughly 15-16% of providers actually measure patient-reported outcomes. It’s because it’s cumbersome. It’s because it’s an additional step they need to do. And Eleos’ approach is running passively in the background, in a secure and seamless way. I think that positions us in a good spot to be able to bring you that data layer around performance and data outcomes.”

In 2023, Joffe plans to continue to innovate in ways that support outcomes without adding stress to clinicians.

“In 2023, we’re doubling down on the CareOps Automation movement we launched  in 2022. We’re going to introduce new, innovative products so that we can support more professionals and solve more problems. 

We’re also going to continue our laser focus on outcomes, always asking how we can measure and enhance consumers outcomes without adding burdens to clinicians who are already giving it their all.

We have a clinical roadmap for 2023, and everything on it is rooted in what drives Eleos: to unlock access and optimize outcomes..”